Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000362082 | SCV000387120 | likely benign | Dystonia 5 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000265088 | SCV000387121 | likely benign | GTP cyclohydrolase I deficiency | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Ce |
RCV000585377 | SCV000692790 | likely benign | not provided | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000687434 | SCV000814999 | uncertain significance | Dystonia 5; GTP cyclohydrolase I deficiency | 2022-11-01 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 69 of the GCH1 protein (p.Pro69Leu). This variant is present in population databases (rs56127440, gnomAD 0.2%). This missense change has been observed in individual(s) with dystonia, parkinsonism, and hereditary spastic paraplegia (PMID: 15389992, 19491146, 25125585, 25398234, 26230973, 27185167, 27217339, 30314816). ClinVar contains an entry for this variant (Variation ID: 161247). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GCH1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mendelics | RCV000265088 | SCV001139462 | benign | GTP cyclohydrolase I deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000585377 | SCV001143995 | uncertain significance | not provided | 2018-12-14 | criteria provided, single submitter | clinical testing | |
Centogene AG - |
RCV000362082 | SCV002059427 | uncertain significance | Dystonia 5 | 2019-09-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003917463 | SCV004729179 | likely benign | GCH1-related condition | 2024-01-22 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
CSER _CC_NCGL, |
RCV000148505 | SCV000190216 | likely benign | Hyperphenylalaninemia due to tetrahydrobiopterin deficiency | 2014-06-01 | no assertion criteria provided | research |